128 related articles for article (PubMed ID: 35147120)
1. Expression and prognostic impact of CD49b in human lung cancer.
Tirilomi A; Elakad O; Yao S; Li Y; Hinterthaner M; Danner BC; Ströbel P; Tirilomis T; Bohnenberger H; von Hammerstein-Equord A
Medicine (Baltimore); 2022 Feb; 101(6):e28814. PubMed ID: 35147120
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic impact of alpha thalassemia/mental retardation X-linked and death domain-associated protein in human lung cancer.
Buentzel J; Yao S; Elakad O; Lois AM; Brünies J; König J; Hinterthaner M; Danner BC; Ströbel P; Emmert A; Bohnenberger H
Medicine (Baltimore); 2019 Aug; 98(31):e16712. PubMed ID: 31374064
[TBL] [Abstract][Full Text] [Related]
4. Role of Annexin A1 in Squamous Cell Lung Cancer Progression.
Elakad O; Li Y; Gieser N; Yao S; Küffer S; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Ströbel P; Bohnenberger H
Dis Markers; 2021; 2021():5520832. PubMed ID: 33959206
[TBL] [Abstract][Full Text] [Related]
5. DDX56 modulates post-transcriptional Wnt signaling through miRNAs and is associated with early recurrence in squamous cell lung carcinoma.
Wu Q; Luo X; Terp MG; Li Q; Li Y; Shen L; Chen Y; Jacobsen K; Bivona TG; Chen H; Zeng R; Ditzel HJ
Mol Cancer; 2021 Aug; 20(1):108. PubMed ID: 34446021
[TBL] [Abstract][Full Text] [Related]
6. Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer.
Arrieta O; Aviles-Salas A; Orozco-Morales M; Hernández-Pedro N; Cardona AF; Cabrera-Miranda L; Barrios-Bernal P; Soca-Chafre G; Cruz-Rico G; Peña-Torres ML; Moncada-Claudio G; Ramirez-Tirado LA
Cancer Med; 2020 Apr; 9(7):2390-2402. PubMed ID: 32043750
[TBL] [Abstract][Full Text] [Related]
7. ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.
Yang Z; Tian H; Bie F; Xu J; Zhou Z; Yang J; Li R; Peng Y; Bai G; Tian Y; Chen Y; Liu L; Fan T; Xiao C; Zheng Y; Zheng B; Wang J; Li C; Gao S; He J
Front Immunol; 2021; 12():788985. PubMed ID: 34992605
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of MAC30 Expression in Human Pure Squamous Cell Carcinomas of the Lung.
Ding H; Gui XH; Lin XB; Chen RH; Cai HR; Fen Y; Sheng YL
Asian Pac J Cancer Prev; 2016; 17(5):2705-10. PubMed ID: 27268655
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.
Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481
[TBL] [Abstract][Full Text] [Related]
11. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic impact of DNA-PK in human lung cancer.
Tirilomi A; Elakad O; Yao S; Li Y; Hinterthaner M; Danner BC; Ströbel P; Tirilomis T; Bohnenberger H; von Hammerstein-Equord A
Medicine (Baltimore); 2023 Mar; 102(9):e33143. PubMed ID: 36862864
[TBL] [Abstract][Full Text] [Related]
14. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
15. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
Qu Y; Yang Y; Ma D; Xiao W
Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
17. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
[TBL] [Abstract][Full Text] [Related]
19. PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer.
Sato T; Kaneda A; Tsuji S; Isagawa T; Yamamoto S; Fujita T; Yamanaka R; Tanaka Y; Nukiwa T; Marquez VE; Ishikawa Y; Ichinose M; Aburatani H
Sci Rep; 2013; 3():1911. PubMed ID: 23714854
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]